Literature DB >> 19215907

Small ubiquitin-like modifiers in cellular malignancy and metastasis.

Keun Il Kim1, Sung Hee Baek.   

Abstract

Small ubiquitin-like modifiers (SUMOs) mediate a variety of cellular functions of protein targets mainly in the nucleus but in other cellular compartments as well, and thereby participate in maintaining cellular homeostasis. SUMO system plays important roles in transcriptional regulation, DNA damage responses, maintaining genome integrity, and signaling pathways. Thus, in some cases, loss of regulated control on SUMOylation/deSUMOylation processes causes a defect in maintaining homeostasis and hence gives a cue to cancer development and progression. Furthermore, recent studies have revealed that SUMO system is involved in cancer metastasis. In this review, we will summarize the possible role of SUMO system in cancer development, progression, and metastasis and discuss future directions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215907     DOI: 10.1016/S1937-6448(08)01807-8

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  13 in total

1.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

Review 2.  Emerging roles of the SUMO pathway in development.

Authors:  Hilda Lomelí; Martha Vázquez
Journal:  Cell Mol Life Sci       Date:  2011-09-04       Impact factor: 9.261

3.  Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia.

Authors:  Terence A Agbor; Alex Cheong; Katrina M Comerford; Carsten C Scholz; Ulrike Bruning; Ambrose Clarke; Eoin P Cummins; Gerard Cagney; Cormac T Taylor
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

4.  Specific domain structures control abscisic acid-, salicylic acid-, and stress-mediated SIZ1 phenotypes.

Authors:  Mi Sun Cheong; Hyeong Cheol Park; Mi Ju Hong; Jiyoung Lee; Wonkyun Choi; Jing Bo Jin; Hans J Bohnert; Sang Yeol Lee; Ray A Bressan; Dae-Jin Yun
Journal:  Plant Physiol       Date:  2009-10-16       Impact factor: 8.340

5.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

6.  The ubiquitin-fold modifier 1 (Ufm1) cascade of Caenorhabditis elegans.

Authors:  Patrick Hertel; Jens Daniel; Dirk Stegehake; Hannah Vaupel; Sareetha Kailayangiri; Clio Gruel; Christian Woltersdorf; Eva Liebau
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

7.  Negative regulation of C/EBPbeta1 by sumoylation in breast cancer cells.

Authors:  Allison A Atwood; Rachel Jerrell; Linda Sealy
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  Screening and identification of SUMP-proteins in sub-acute treatment with diazinon.

Authors:  Rezvan Yazdian-Robati; Atena Pourtaji; Marzieh Rashedinia; Hossein Hosseinzadeh; Maryam Ghorbani; BiBi Marjan Razavi; Mohammad Ramezani; Khalil Abnous
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

9.  Identification of druggable cancer driver genes amplified across TCGA datasets.

Authors:  Ying Chen; Jeremy McGee; Xianming Chen; Thompson N Doman; Xueqian Gong; Youyan Zhang; Nicole Hamm; Xiwen Ma; Richard E Higgs; Shripad V Bhagwat; Sean Buchanan; Sheng-Bin Peng; Kirk A Staschke; Vipin Yadav; Yong Yue; Hosein Kouros-Mehr
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

10.  High glucose induces sumoylation of Smad4 via SUMO2/3 in mesangial cells.

Authors:  Xueqin Zhou; Chenlin Gao; Wei Huang; Maojun Yang; Guo Chen; Lan Jiang; Fang Gou; Hong Feng; Na Ai; Yong Xu
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.